7-beta-Hydroxylathyrol

CAS No. 34208-98-5

7-beta-Hydroxylathyrol( —— )

Catalog No. M18444 CAS No. 34208-98-5

7β-Hydroxylathyrol is a diterpenoid extract from the seed oil of Caper Spurge and displays P-gp inhibition resulting in cytotoxic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 In Stock
5MG 93 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-beta-Hydroxylathyrol
  • Note
    Research use only, not for human use.
  • Brief Description
    7β-Hydroxylathyrol is a diterpenoid extract from the seed oil of Caper Spurge and displays P-gp inhibition resulting in cytotoxic properties.
  • Description
    7β-Hydroxylathyrol is a diterpenoid extract from the seed oil of Caper Spurge and displays P-gp inhibition resulting in cytotoxic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    Pim
  • Recptor
    P-gp?(P-glycoprotein)
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    34208-98-5
  • Formula Weight
    350.45
  • Molecular Formula
    C20H30O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 16.67 mg/mL 47.57 mM
  • SMILES
    CC1CC2(C(C1O)C(C(=C)C(CC3C(C3(C)C)C=C(C2=O)C)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jiao, W. et al.: Bioorg, Med. Chem., 17, 4786 (2009); Bicchi, C. et al.: Phytochem. Anal., 12, 255 (2001)
molnova catalog
related products
  • LGB-321

    LGB-321 (LGB321) is a potent and specific pan-Pim inhibitor with Ki of 1/2.1/0.8 pM for Pim1/2/3, respectively.

  • TCS PIM-1 1

    A potent, selective, ATP-competitive Pim-1 kinase inhibitor with IC50 of 50 nM.

  • 1-phenoxazin-10-ylet...

    1-phenoxazin-10-ylethanone is a Pim-2 inhibitor. 1-phenoxazin-10-ylethanone induces apoptosis and autophagic cell death in triple-negative human breast cancer.